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At two consecutive ‘checkpoints’ in their development,
T cells have to be rescued from programmed cell death
and to choose between distinct lineage fates; recent
results show that the Notch transmembrane receptor
can significantly influence T-cell development at both of
these points.
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As lymphocytes develop from pluripotent stem cells, in
order to survive and mature they need to productively
rearrange their antigen-receptor genes, which are present
in pieces in the germ-line genome. Several ‘checkpoints’
have been identified at which developing T and B
lymphocytes have to make a particular type of receptor in
order to proceed to the next developmental stage. In the
case of T cells, not only whether they will survive but also
which particular lineage they will follow is determined at
these checkpoints.
T-cell receptors come in two main kinds, ab and gd, both
heterodimers; ab and gd T cells have distinct properties,
however, so that the two lineages can be defined
independently of the particular type of receptor expressed
(see below). Early in the T-cell lineage, g, d and b T-cell
receptor genes are rearranged (Fig. 1). If the g and d genes
are rearranged productively — the component parts being
joined in the correct reading frame — then the cells express
a gd T-cell receptor at the surface and subsequently follow
the gd lineage. If the gd genes are not both rearranged pro-
ductively, then the cells can go on and attempt to enter the
ab lineage. This is consistent with the finding that there is
selection against productive g and d gene rearrangements in
ab lineage cells [1–3]
It appears that the decision to become a gd T cell is not
strictly determined by the type of receptor — either gd or
ab — that is expressed, but rather by the timing of recep-
tor expression. Thus, if an ab T-cell receptor is expressed
abnormally early in transgenic mice, then cells are formed
with properties characteristic of being on the gd lineage —
for example, they crucially depend on the expression of
the cytokine receptor g chain [4] — but that nevertheless
Figure 1
Early in T-cell development, the g, d and b chain T-cell receptor genes
are rearranged, but the a chain gene remains unrearranged. Cells that
can make a gd T-cell receptor become gd lineage cells; recent results
show that Notch can induce expression of CD4 and CD8 in these cells,
though most may consequently turn off cell-surface gd T-cell receptor
expression. Cells that cannot make a gd T-cell receptor, but that
productively rearrange a b-chain gene, express the ‘pre-T-cell receptor’ —
a heterodimer of a b chain and a pre-T-cell receptor a chain. These cells
expand, rearrange their a chain locus and become CD4+ CD8+ ab-
expressing cells; Notch supports the development of these cells.
Immature CD4+CD8+ ab+ cells can be rescued from programmed cell
death if their receptor binds to a class I or class II MHC molecule.
Ligation of class I MHC molecules results in the formation of mature
CD4– CD8+ cells, and this pathway is promoted by Notch. Ligation of
class II MHC molecules results in the formation of CD4+ CD8– cells.
Some CD4– CD8+ cells with class II MHC specific T-cell receptors may
result from the influence of an active Notch receptor.
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express ab, rather than gd, T-cell receptors [5]. Early
expression of either gd or ab T-cell receptor transgenes
does not, however, entirely block the development of ab
T cells, indicating that neither the quality of the T-cell
receptor nor the timing of T-cell receptor expression are
the only factors determining commitment to the ab
lineage [5,6]. 
Cells that enter the ab lineage first express ‘pre-T-cell
receptors’, heterodimers of the T-cell receptor b chain and
the ‘pre-T-cell receptor’ a chain (Fig. 1). Expression of this
receptor by cells with a productively-rearranged b- chain
gene rescues them from programmed cell death, terminates
further rearrangement of the b-, d- and probably also g-
chain genes, and induces a strong wave of proliferation in
the selected cells that eventually express CD4 and CD8
cell-surface molecules [7]. CD4 and CD8 are believed to be
markers of the ab lineage; mature ab T cells express either
CD4 or CD8, which act as coreceptors in cells specific for
peptide antigens bound to, respectively, class II or class I
major histocompatibility complex (MHC) molecules.
Mutant mice that lack the pre-T-cell receptor a chain can,
however, still generate CD4+CD8+ cells in several ways,
and some of these can express bone fide gd T-cell receptors;
again, therefore, the correlation between receptor type and
cell phenotype is good, but not perfect [7].
A second checkpoint in the development of ab T cells
depends on the binding of the T-cell receptor to thymic
MHC molecules, which can rescue immature ab T cells
from programmed cell death (Fig. 1). This rescue is again
associated with lineage commitment: depending on
whether the T-cell receptor is specific for class I or class II
MHC molecules, the rescued cells will have the
CD4– CD8+ cytolytic or CD4+ CD8– helper T-cell pheno-
type [8]. Even here, however, there is no perfect correla-
tion between T-cell receptor specificity and lineage
commitment, because CD4– CD8+ cytolytic T cells can be
selected that express a T-cell receptor specific for class II
MHC molecules [9]. 
At both these checkpoints in T-cell development, the mol-
ecular mechanisms specifying cell survival and, especially,
lineage commitment have been largely unknown. Two
recent papers [10,11] have now reported evidence impli-
cating Notch as a key player in the lineage decisions at
both of these checkpoints. Notch was originally identified
in the fruitfly Drosophila, where, in ectodermal precursor
cells, activated Notch inhibits neural differentiation so that
the cells follow the alternative, epidermal fate. It appears
that neighbouring precursors expressing slightly different
levels of Notch and its ligand can influence each other in
such a way that an initially small difference becomes exag-
gerated, and one cell comes to express only the receptor,
and differentiates into an epidermal cell, and the other
comes to express only the ligand, and differentiates into a
neuron. This is thought to explain why, in mosaic fruitflies,
heterozygous Notch+/– precursors — which presumably start
off expressing a lower than normal level of Notch — adopt
mostly the neural fate when next to wild-type precursors,
but both neural and epidermal fates when developing in
the absence of wild-type cells [12]. Notch homologs have
been implicated in a number of different developing
systems in various species. In hemopoietic cells of
mammals, for example, Notch can inhibit differentiation
into myeloid cells and thereby increase cell numbers of
less differentiated hemopoietic precursors [13]. 
The two new studies [10,11] have investigated the role of
Notch in lymphocyte — particularly T-cell — differentia-
tion. Washburn et al. [10] studied lymphocyte develop-
ment in mice with chimeric hematopoietic systems, in
which some cells are wild-type and other heterozygous for
a Notch mutation. They found that, in such chimeras, the
Notch+/– precursors cells produced the same number of B
cells, slightly fewer gd T cells, but significantly fewer ab T
cells than were produced by the wild-type precursors. In
contrast, in control chimeras where all the cells are Notch+/–,
the Notch+/– precursors produced the same ratio of ab T
cells to B cells as wild-type mice. From these observations,
it was concluded that, in the presence of wild-type cells,
cells expressing relatively low Notch receptor levels tend
to favour the gd over the ab lineage. One caveat about
these experiments is that data on the ab to gd lineage ratio
were only presented for the wild-type–Notch+/– chimeras,
and not for the control Notch+/––Notch+/– chimeras [10]. 
The caveat notwithstanding, additional data suggest that
Notch does act to promote differentiation to the ab T-cell
lineage. An activated form of Notch was expressed from a
transgene in mice that were relatively deficient in ab
lineage cells, either because they expressed g and d chain
transgenes or because they lacked the b chain as a result of
a mutation. In these mice, it was found that expression of
activated Notch led to an increase in the proportion of
CD4+CD8+ cells with productive gd gene rearrangements
[10]. In the b chain mutant mice, it was actually not clear
whether there was an absolute increase in the number of
CD4+CD8+ cells with or without productive gd gene
rearrangements; it did appear, however, that within the
CD4+CD8+ population there had at some point been selec-
tion for cells with in-frame gd gene rearrangements
(although these cells no longer expressed gd T-cell recep-
tors at the cell surface). Gene rearrangement was clearly rel-
evant to the observed effect of the activated Notch, as it did
not affect development in rearrangement-deficient, rag
mutant mice. It was concluded from these experiments that
activated Notch could force gd T-cell receptor expressing
cells into the CD4+8+ ab lineage, so that the cells adopt an
ab phenotype, even though they are carrying productively
rearranged g- and d-chain genes, but not productively
rearranged a- or b-chain genes. 
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In the other paper, Robey et al. [11] studied the effect of
expressing activated Notch on the second checkpoint in
T-cell development: the point at which cells choose
whether to develop into CD4– CD8+ or CD4+ CD8– cells.
They found that expression of activated Notch increased
the production of CD4– CD8+ cells and decreased the pro-
duction of CD4+ CD8– cells. The activated Notch also
caused an increase in the proportion of CD4– CD8+ cells
in class I MHC-deficient mutant mice, but not in mice
deficient in expression of both class I and class II MHC
molecules [11]. Robey et al. [11] concluded that Notch
activity forces cells into the CD4– CD8+ lineage, and away
from the CD4+ CD8– lineage.
Although the interpretation of these very interesting
observations [10,11] is still open to argument, it is clear
that activated Notch can have a profound effect on T-cell
development. What is less clear is the mechanism by
which Notch exerts its effects: is it really the lineage deci-
sion that is made by Notch? This question is difficult to
answer, because it is conceivable that Notch confers selec-
tive survival and/or cell proliferation on cells that have
already made a lineage decision, but that are not fully dif-
ferentiated. This would explain the increase in the propor-
tion of ‘unorthodox’ cells — like the CD4– CD8+ cells
expressing class II MHC-specific ab T-cell receptors, or
the CD4+ CD8+ cells with productively rearranged gd T-
cell receptor genes.
It is more difficult to explain the apparent deficit in some
T-cell subsets seen in certain situations. This may reflect a
competition that favours cells expressing higher levels of
Notch. In the case of the wild-type–Notch+/– chimeras, for
instance, one could argue that the wild-type ab lineage pre-
cursors outcompete the Notch+/– precursors, and that this is
the only reason why they contribute more to the ab
lineage. In the case of the CD4–CD8+ T cells, one could
argue that these cells, when expressing higher Notch levels,
outcompete CD4+CD8– cells that express lower Notch
levels soon after the lineage decision has been made. This
would be consistent with the notion that Notch favours sur-
vival or expansion of some hemopoietic cells. [13].
Thus, in a strict sense, the new data do not directly show
that Notch makes lineage decisions during lymphocyte
development, although they are perfectly consistent with
such a notion The final word is not in on this issue, but
these experiments have certainly added another level of
complexity to our appreciation of lymphocyte develop-
ment and lymphocyte lineage decision.
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